NO308855B1 - Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein - Google Patents

Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein

Info

Publication number
NO308855B1
NO308855B1 NO933269A NO933269A NO308855B1 NO 308855 B1 NO308855 B1 NO 308855B1 NO 933269 A NO933269 A NO 933269A NO 933269 A NO933269 A NO 933269A NO 308855 B1 NO308855 B1 NO 308855B1
Authority
NO
Norway
Prior art keywords
leu
immunodeficiency virus
human immunodeficiency
polypeptides derived
polypeptide
Prior art date
Application number
NO933269A
Other languages
English (en)
Norwegian (no)
Other versions
NO933269D0 (no
NO933269L (no
Inventor
Francesca Chiodi
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of NO933269D0 publication Critical patent/NO933269D0/no
Publication of NO933269L publication Critical patent/NO933269L/no
Publication of NO308855B1 publication Critical patent/NO308855B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO933269A 1991-03-15 1993-09-14 Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein NO308855B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,296 US5229364A (en) 1991-03-15 1991-03-15 Polypeptides derived from the human immunodeficiency virus endonuclease protein
PCT/US1992/001813 WO1992016219A1 (fr) 1991-03-15 1992-03-03 Polypeptides derives de la proteine endonuclease du virus de l'immunodeficience humaine

Publications (3)

Publication Number Publication Date
NO933269D0 NO933269D0 (no) 1993-09-14
NO933269L NO933269L (no) 1993-11-12
NO308855B1 true NO308855B1 (no) 2000-11-06

Family

ID=24689836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933269A NO308855B1 (no) 1991-03-15 1993-09-14 Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein

Country Status (13)

Country Link
US (2) US5229364A (fr)
EP (1) EP0575522B1 (fr)
JP (1) JPH07119235B2 (fr)
AT (1) ATE166068T1 (fr)
AU (1) AU683812B2 (fr)
CA (1) CA2105664C (fr)
DE (1) DE69225473T2 (fr)
DK (1) DK0575522T3 (fr)
ES (1) ES2118131T3 (fr)
FI (1) FI111731B (fr)
IE (1) IE920832A1 (fr)
NO (1) NO308855B1 (fr)
WO (1) WO1992016219A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein
ES2267094T3 (es) * 1991-12-23 2007-03-01 Novartis Vaccines And Diagnostics, Inc. Conjunto de sondas de vih para su uso en ensayos de hibridacion en sandwich en fase de disolucion.
US5590213A (en) * 1995-02-15 1996-12-31 David Clark Company Inc. Headset with adjustable headpad
DE19717187A1 (de) * 1997-04-24 1998-10-29 Pagendarm Technologie Gmbh Vorrichtung zur Behandlung, insbesondere Trocknung von Materialbahnen
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
US20050031639A1 (en) 2003-05-12 2005-02-10 Yamamoto Janet K. Materials and methods for immunizing against FIV infection
WO2010056441A1 (fr) * 2008-11-17 2010-05-20 Dow Global Technologies Inc. Procédés de réduction du formaldéhyde transporté par l’atmosphère

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620330B2 (en) * 1987-05-29 1992-02-20 Smithkline Beckman Corporation Immunodiagnostic assays using chimeric antigens
FR2640877A1 (fr) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
AU5184190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein

Also Published As

Publication number Publication date
DE69225473T2 (de) 1998-10-01
AU7546896A (en) 1997-02-20
JPH07119235B2 (ja) 1995-12-20
AU683812B2 (en) 1997-11-20
US5401628A (en) 1995-03-28
AU1572592A (en) 1992-10-21
EP0575522A1 (fr) 1993-12-29
AU671950B2 (en) 1996-09-19
WO1992016219A1 (fr) 1992-10-01
JPH06505275A (ja) 1994-06-16
FI934022A (fi) 1993-09-14
DE69225473D1 (de) 1998-06-18
FI111731B (fi) 2003-09-15
FI934022A0 (fi) 1993-09-14
NO933269D0 (no) 1993-09-14
IE920832A1 (en) 1992-09-23
ATE166068T1 (de) 1998-05-15
ES2118131T3 (es) 1998-09-16
CA2105664C (fr) 1998-08-25
EP0575522B1 (fr) 1998-05-13
CA2105664A1 (fr) 1992-09-16
EP0575522A4 (fr) 1994-11-23
US5229364A (en) 1993-07-20
DK0575522T3 (da) 1998-10-07
NO933269L (no) 1993-11-12

Similar Documents

Publication Publication Date Title
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
ATE236981T1 (de) Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
NO950668L (no) Peptider avledet fra et retrovirus fra HIV-gruppen og anvendelser derav
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
ATE85809T1 (de) Herstellung des menschlichen von-willebrandfaktors durch rekombinante dns.
NO933269L (no) Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein
DE69131662D1 (de) Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
ATE121754T1 (de) Vakzine gegen bordetella.
EP0225020A3 (fr) Peptides comprenant dans leur séquence des unités sélectionnées parmi les restes d'acides aminés 17 à 24 du VIP
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DK0426314T3 (da) HIV-relaterede peptider
PT87239A (pt) Process for the preparation of peptides
WO1994004565A3 (fr) Vaccin vnpi
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.

Legal Events

Date Code Title Description
MK1K Patent expired